Outsourced Imaging to Radiology Slows Fertility Care as Patient Loads Climb

Traditional workflows delay diagnostics, disrupt patient diagnosis

This News Digest Story is paid featured content.
BY INSIDE REPRODUCTIVE HEALTH

 

Limited Imaging Costs Clinics Time and Control

Fertility clinics relying on traditional imaging systems are facing mounting inefficiencies as diagnostic demand grows. Hysterosalpingography (HSG) and other imaging tools using ionizing radiation often require external referrals, introduce delays, and often cannot deliver the clarity needed to assess uterine and tubal health with confidence. These constraints impact patient care and operational throughput—especially as rising infertility rates and declining REI workforce availability stretch clinical capacity.

REIs and OB/GYNs report frustration with inconclusive imaging results and time lost navigating outside imaging referrals. When critical diagnostics like tubal patency evaluations require offsite referrals or delay in diagnostic information, continuity of care breaks down. As practices contend with growing patient volumes and reduced diagnostic timelines, the current toolset is hindering progress and must be modernized.


Still Referring Out for Tubal Patency?

Turn 60 Minutes into a Faster, Cheaper, In-House Fertility Workflow

  • Traditional imaging delays diagnosis, wastes time, and increases costs. In this free 60-minute strategy session, discover how Samsung’s  3D imaging tools transform your clinic’s diagnostics with:

    • Instant, in-office evaluation of uterine and tubal health

    • Reduced patient discomfort, no radiation, and fewer referrals

    • Clearer results—even for newer ultrasound users

    See how top REIs are cutting diagnostic delays and building patient trust.


    ➡ Schedule your strategy session now — and modernize fertility care in one visit.


Fewer Steps to Capture Coronal Plane with Automatic Tools

One of the primary challenges in fertility diagnostics is achieving accurate imaging of the uterus and fallopian tubes—especially for clinicians less experienced with ultrasound. Traditional methods can obscure findings due to poor contrast quality, bubble artifacts, or non-optimized imaging settings.

 

Samsung’s UterineContour displays coronal uterus with two clicks.

 

Samsung’s technology now allows clinicians to acquire coronal plane views with fewer manual steps. These tools leverage automation and intelligent presets to simplify image acquisition—helping reduce variability between users and ensuring reproducibility across cases. With fewer steps and greater imaging precision, the learning curve for less experienced clinicians flattens, and workflow efficiency improves across the fertility care team.

By streamlining the process and reducing reliance on operator skill alone, the Samsung system enhances diagnostic confidence while minimizing patient discomfort and time spent in the exam room. For busy fertility clinics under pressure to serve growing patient volumes, this represents a meaningful advancement in both clinical quality and operational performance.

Foam Contrast + Cine Imaging Improve Clarity Where Traditional Solutions Break Down

In conventional Hysterosalpingo Contrast Sonography (HyCoSy), agitated fluid may cause image artifacts, obscuring the fallopian tubes and results may be inconclusive or not provided completely. Foam contrast mediums often offer improved visualization.

Samsung’s approach includes 2D and 3D Cine imaging to dynamically demonstrate fluid flow and tubal patency, enabling providers to see changes in real time. Additionally, Realistic Vue render modes enhance anatomical structures for improved clarity. These enhancements support not only better diagnosis but reduce dependence on external imaging facilities, keeping workflows within the clinic and under clinician control.

A study from 2021 found that HyCoSy is the gold standard for accessing tubal patency: a trusted technique that is accurate and effective. 

In-Office HyCoSy Cuts Time, Cost, and Referral Burden

Samsung’s system design centers on bringing formerly outsourced diagnostics in-house. By enabling REIs and APPs to perform HyCoSy and saline sonograms during routine appointments, clinics can avoid the cost and logistical complexity of offsite imaging. According to the company, these integrations lead to faster diagnosis, reduced patient anxiety, with improved comfort during the examination as well as providing fewer delays between evaluation and treatment planning.

Clinics adopting this model report improved diagnostic confidence. Providers using 3D renderings, video clips with real-time cine capabilities gain more reliable imaging data while maintaining a patient-friendly experience.

Scalable for High-Volume Practices, Accessible to New Users

As infertility rates rise and the pool of REIs continues to shrink, the pressure on clinics to do more with fewer hands has intensified. Many practices lack the bandwidth or training to adopt new imaging protocols. Samsung’s tools are designed to be easily accessible—even for users with limited ultrasound experience—by minimizing learning curves and automating acquisition processes.

This makes the technology scalable for growing networks while remaining practical for private clinics. With imaging tools that reduce acquisition and manipulation time, clinics can streamline training, expand internal capabilities, and move toward diagnostic self-sufficiency.


Still Referring Out for Tubal Patency?

Turn 60 Minutes into a Faster, Cheaper, In-House Fertility Workflow

  • Traditional imaging delays diagnosis, wastes time, and increases costs. In this free 60-minute strategy session, discover how Samsung’s  3D imaging tools transform your clinic’s diagnostics with:

    • Instant, in-office evaluation of uterine and tubal health

    • Reduced patient discomfort, no radiation, and fewer referrals

    • Clearer results—even for newer ultrasound users

    See how top REIs are cutting diagnostic delays and building patient trust.


    ➡ Schedule your strategy session now — and modernize fertility care in one visit.

 

This News Digest Story is paid featured content. The advertiser has had editorial input and control over its creation. However, the views and opinions expressed in this article do not necessarily represent the views of Inside Reproductive Health. The sponsorship of this content does not imply an endorsement by Inside Reproductive Health.